InvestorsHub Logo
icon url

Minnesinger

12/09/20 9:24 PM

#336090 RE: multiples #336087

This is the second time this year...

Seqens has referenced Brilacidin in one of their publications.

https://www.seqens.com/en/what-flow-chemistry-and-biocatalysis-bring-to-synthesize-a-typical-small-molecule-candidate-against-covid-19-epidemic/

I asked in May and I'll ask again: who is Seqens and why are they promoting our molecule?